Official UK procurement notice
NHS National Framework for Transition products (Nilotinib and Ticagrelor)
Authority: NHS England (Central government)·Consortium: 2 public authorities
Re-procurement openNHS National Framework for Lenvatinib · bids close
What is being bought
Published requirement descriptionProject title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025
Offer reference number: CM/TNS/24/5721
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5721/01 - Nilotinib and Ticagrelor
Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)
Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)
Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
Additional Unsuccessful supplier not listed due to technical error:
Torrent Pharma (UK) Ltd
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Closed framework · open framework scheme (admission reopens)
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 17 bids received · 8 suppliers appointed
- Framework period
- 1 yr 5 mo · up to 3 yrs 5 mo from 1 Sept 2025
- Scheme runs until
- 31 Jan 2029
- Buyer regions
- UKC, UKD, UKE, UKF, UKG, UKH, UKI
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£29,042,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion: 100%
Published award criteria (1)
- Price is not the only award criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework for Transition products (Nilotinib and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Open framework scheme
- Who may use this agreement
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points · open scheme: new suppliers can join during the term
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Apr 2025, 12:44 BST
- Last source update
- 20 Aug 2025, 08:17 BST
- Award evaluation window
- Submission end – 25 Jun 2025
- Authority reference
C352808- FTS notice number
2025/S 000-019302- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04ff90Find a Tender
How it was run
Official notice- Appointment period ends
- 9 Jun 2025, 13:00 BST
- Clarification deadline
- 2 Jun 2025, 13:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗ Additional info obtained from the abovementioned address Tenders must be submitted to the abovementioned address
Timeline
9 Apr 2025 → 1 Sept 2025 · 11 dates- Planning notice published9 Apr 2025, 12:44 BST
- Market engagement25 Apr 2025, 23:59 BST
NHS England is pleased to invite suppliers to contact us in relation to the upcoming tender for NHS National Framework for Transition products commencing 1st September 2025 (Ticagrelor and Nilotinib ) Please contact [email protected] for further information and/or to register your interest.
- Next notice expected30 Apr 2025, 23:59 BST
- Tender notice published7 May 2025, 10:42 BST
- Clarification questions by2 Jun 2025, 13:00 BST
- Admission / appointment period endsperiod end, not a bid countdown9 Jun 2025, 13:00 BST
- Award decision expected by25 Jun 2025, 23:59 BST
- Assessment summaries sent10 Jul 2025, 00:00 BST
- Standstill ends23 Jul 2025, 23:59 BST
- Latest notice published20 Aug 2025, 08:17 BST
- Contract starts1 Sept 2025, 00:00 BST
Notice history
14 events · 6 releases on Find a Tender · since 9 Apr 2025- Preliminary market engagement notice published9 Apr 2025, 12:44 BSTUK2
- Tender notice published7 May 2025, 10:42 BSTUK4
- Status changed to active7 May 2025, 10:42 BST
- Procurement method changed7 May 2025, 10:42 BST
- Deadline published: 2 Jun 2025, 13:00 BST7 May 2025, 10:42 BST
- Tender notice published7 May 2025, 11:50 BSTUK4
- Deadline moved to 9 Jun 2025, 13:00 BST7 May 2025, 11:50 BST+7 days · was 2 Jun 2025, 13:00 BST
- Contract award notice published11 Jul 2025, 10:52 BSTUK6
- Status changed to complete11 Jul 2025, 10:52 BST
- Buyer details updated11 Jul 2025, 10:52 BST
- Contract award notice published11 Jul 2025, 13:24 BSTUK6
- Contract signature expected25 Jul 2025, 23:59 BSTscheduled
- Contract details notice published20 Aug 2025, 08:17 BSTUK7
- Buyer details updated20 Aug 2025, 08:17 BST
Published amendments (1)
Enquiry Deadline updated to 02/06/2025 13:00 Submission Deadline updated to 09/06/2025 13:00 ITO Documents Attached
Routine re-releases (6)
- 2025-05: 2 releases · 7 May 2025, 7 May 2025
- 2025-04: 1 release · 9 Apr 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast£22,097,000 is the framework's published maximum, restated by the publisher on 2 award rows. It is one ceiling, not 2 separate sums, and no share per lot is published; those rows read “ceiling above”.
| Awarded to | Value | Date | Status |
|---|---|---|---|
| ACCORD-UK LTD, ASTRAZENECA UK LIMITED, CST Pharma Ltd, Dr Reddy's Laboratories (UK) Ltd, MSN Laboratories Europe LimitedSME, NOVARTIS PHARMACEUTICALS UK LIMITED +2 more1 Sept 2025 – 31 Jan 2027 · up to 31 Jan 2029Extensions: option or options to extend (at the discretion of the Authority) up to maximum of 24 months. | ceiling above | 12 Jun 2025 | Awarded |
| ACCORD-UK LTD, ASTRAZENECA UK LIMITED, CST Pharma Ltd, Dr Reddy's Laboratories (UK) Ltd, MSN Laboratories Europe LimitedSME, NOVARTIS PHARMACEUTICALS UK LIMITED +2 more1 Sept 2025 – 31 Jan 2027 · up to 31 Jan 2029Extensions: Option or options to extend (at the discretion of the Authority) up to maximum of 24 months. | ceiling above | 12 Jun 2025standstill to 23 Jul 2025 | Standstill |
Contracts
NHS National Framework for Transition products (Nilotinib and Ticagrelor) · ACCORD-UK LTD, ASTRAZENECA UK LIMITED, CST Pharma Ltd, Dr Reddy's Laboratories (UK) Ltd, MSN Laboratories Europe LimitedSME, NOVARTIS PHARMACEUTICALS UK LIMITED +2 more
- Signed
- 4 Aug 2025
- Value
- £22,097,000
- Period
- 1 Sept 2025 – 31 Jan 2027 · up to 31 Jan 2029 with extensions
- Status
- active
- Extensions
- option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 17final-stage tenders · 18 at stage one | 10 | 0 | — |
Who bid
- wonZYDUS PHARMACEUTICALS UK LTD · South West England + ACCORD-UK LTD · South West England · consortium
- wonACCORD-UK LTD · South West England + ASTRAZENECA UK LIMITED · Greater London · consortium
- wonASTRAZENECA UK LIMITED · Greater London + C. S. T. PHARMA LIMITED · West Midlands · consortium
- wonC. S. T. PHARMA LIMITED · West Midlands + DR REDDY'S LABORATORIES (UK) LIMITED · East of England · consortium
- wonDR REDDY'S LABORATORIES (UK) LIMITED · East of England + MSN LABORATORIES EUROPE LIMITEDSME · East of England · consortium
- wonMSN LABORATORIES EUROPE LIMITEDSME · East of England + NOVARTIS PHARMACEUTICALS UK LIMITED · Greater London · consortium
- wonNOVARTIS PHARMACEUTICALS UK LIMITED · Greater London + ZENTIVA PHARMA UK LIMITED · Greater London · consortium
- wonZENTIVA PHARMA UK LIMITED · Greater London + ZYDUS PHARMACEUTICALS UK LTD · South West England · consortium
- did not winAMAROX LIMITEDSME · Greater London
- did not winASCEND LABORATORIES (UK) LIMITEDSME · Greater London
- did not winBROWN & BURK UK LIMITED · Greater London
- did not winCRESCENT PHARMA LIMITED · South East England
- did not winGEDEON RICHTER (UK) LIMITED · Greater London
- did not winMORNINGSIDE PHARMACEUTICALS LIMITED · East Midlands
- did not winNOVUMGEN LIMITED · Greater London
- did not winTEVA UK LIMITED · Yorkshire and the Humber
- did not winTHORNTON & ROSS LIMITED · Yorkshire and the Humber
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
2 public bodies on the noticeFramework contractors & participating bidders
17 commercial parties on the notice · 8 awarded- AMAROX LIMITEDBidder / tenderer
- ASCEND LABORATORIES (UK) LIMITEDBidder / tenderer
- Accord-UK LtdFramework contractor
- AstraZenecaFramework contractor
- BROWN & BURK UK LIMITEDBidder / tenderer
- C. S. T. PHARMA LIMITEDFramework contractor
- CRESCENT PHARMA LIMITEDBidder / tenderer
- Dr.Reddy's Laboratories (UK) LimitedFramework contractor
- GEDEON RICHTER (UK) LIMITEDBidder / tenderer
- MORNINGSIDE PHARMACEUTICALS LIMITEDBidder / tenderer
Show 7 more suppliers
- MSN Laboratories Europe LimitedFramework contractor
- NOVUMGEN LIMITEDBidder / tenderer
- Novartis Pharmaceuticals UK LtdFramework contractor
- TEVA UK LIMITEDBidder / tenderer
- THORNTON & ROSS LIMITEDBidder / tenderer
- Zentiva Pharma UK LtdFramework contractor
- Zydus Pharmaceuticals UK LtdFramework contractor
Official documents & specifications (8)
Official links; attachments are not copiedTender pack and attachments
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender